Biocon Biologics
Ragubalaji Neerkathalingam currently serves as Lead Global Program Management at Biocon Biologics since January 2022, bringing extensive experience in program management within the biopharma sector. Prior to this role, Ragubalaji held the position of Lead Program Manager at Biopharma - Stelis from June 2019 to December 2021 and served as Assistant General Manager for Formulation R&D Program Management at USV LIMITED from February 2016 to May 2019, overseeing small molecule and peptide formulation development programs. Previous experience includes managing sterile injectable formulation R&D projects at Hospira, A Pfizer Company, from April 2012 to January 2016 and overseeing oncology drug development at Jubilant Innovation Limited as Assistant Manager. Ragubalaji holds an Executive Programme in Strategy and Leadership from the Indian Institute of Management Kashipur and a degree from Madurai Kamaraj University.
Previous companies
This person is not in any teams
This person is not in any offices
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics